Solasia Pharma K.K. (FRA:9SO)

Solasia Pharma K.K. Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-1,796	-1,961	-1,135	-2,492	-2,442	-4,159
Depreciation & Amortization	-96	195	500	534	495	496
Loss (Gain) From Sale of Assets	-	959	-	431	-	800
Loss (Gain) on Equity Investments	1	4	5	3	-	-
Other Operating Activities	-1	-6	-36	-12	-2	28
Change in Accounts Receivable	-33	-164	540	-446	51	-160
Change in Inventory	37	-5	-108	-14	4	-1
Change in Accounts Payable	307	-92	-118	-65	-626	225
Change in Other Net Operating Assets	-	37	-7	-13	47	-18
Operating Cash Flow	-464	-1,033	-359	-2,074	-2,473	-2,789
Capital Expenditures	-1	-1	-	-	-2	-10
Cash Acquisitions	-	-	-	-14	-	-
Sale (Purchase) of Intangibles	-	-	-	-403	-161	-161
Other Investing Activities	-1	1	-	-1	-1	-
Investing Cash Flow	-79	-	-	-418	-164	-171
Long-Term Debt Issued	-	500	-	500	-	2,500
Long-Term Debt Repaid	-	-500	-	-500	-1,000	-1,500
Net Debt Issued (Repaid)	-33	-	-	-	-1,000	1,000
Issuance of Common Stock	1,370	1,215	318	2,621	1,403	874
Other Financing Activities	-	-35	-43	-50	-42	-45
Financing Cash Flow	1,337	1,180	275	2,571	361	1,829
Foreign Exchange Rate Adjustments	-6	11	7	10	25	-20
Miscellaneous Cash Flow Adjustments	1	-1	1	-1	1	-
Net Cash Flow	789	157	-76	88	-2,250	-1,151
Free Cash Flow	-465	-1,034	-359	-2,074	-2,475	-2,799
Free Cash Flow Margin	-142.64%	-327.21%	-58.18%	-189.93%	-442.75%	-616.52%
Free Cash Flow Per Share	-2.05	-5.20	-2.13	-13.65	-19.02	-23.85
Cash Interest Paid	2	1	-	1	1	1
Cash Income Tax Paid	1	1	25	28	22	14
Levered Free Cash Flow	-756	-1,252	62.13	-1,949	-1,667	-2,237
Unlevered Free Cash Flow	-742.25	-1,249	62.13	-1,937	-1,653	-2,210
Change in Working Capital	311	-224	307	-538	-524	46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.